Future of Gene Therapy
| dc.contributor.author | lasheeka, Mohamed Abullah | |
| dc.date.accessioned | 2019-02-13T09:53:06Z | |
| dc.date.available | 2019-02-13T09:53:06Z | |
| dc.date.issued | 2018-06-04 | |
| dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/464 | |
| dc.description | Gene therapy is when DNA is introduced into a patient to treat a genetic disease. The new DNA usually contains a functioning gene to correct the effects of a disease-causing mutation. Gene therapy uses sections of DNA? (usually genes?) to treat or prevent disease. The DNA is carefully selected to correct the effect of a mutated gene that is causing disease. The technique was first developed in 1972 but has, so far, had limited success in treating human diseases. Gene therapy may be a promising treatment option for some genetic diseases including muscular dystrophy, and cystic fibrosis, There are two different types of gene therapy depending on which types of cells are treated | en_US |
| dc.description.abstract | Although up to this point its success has been very limited and the fact that’s its had many problems the most important of which being ethical problems. Gene therapy is a very prospecting technique that potentially can have many different therapeutic potentials. 2017 has been a pretty eventful year for gene therapy and this report will mainly aim to discuss the future gene therapy and some of the prospecting cases that it has had in the past year. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.title | Future of Gene Therapy | en_US |
| dc.type | Other | en_US |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution 3.0 United States